Evidence map›Paper›PMID 1295376›Full record

ArticleAgents and actions1992

Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na).

H Nagai, K Kitagaki, K Kuwabara, A Koda

Abstract read
PubMed Publisher
In one paragraph

Article in Agents and actions, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Zinc porphyrins: potent inhibitors of hematopoieses in animal and human bone marrow.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  4. The effects of mesoporphyrin on experimental arthritis in mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 1996
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

H NagaiDepartment of Pharmacology, Gifu Pharmaceutical University, Japan.
K Kitagaki
K Kuwabara
A Koda
Gifu Pharmaceutical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-inflammatory properties of zinc protoporphyrin disodium (Zn-PP-2Na) were studied. Zn-PP-2Na exhibits anti-allergic action against type III and IV reactions (passive Arthus reaction in rats and tuberculin-induced footpad reaction in mice), but does not affect type I and II reactions (homologous passive cutaneous anaphylaxis in mice and reversed cutaneous anaphylaxis in rats). Zn-PP-2Na also clearly inhibits type II collagen-induced arthritis in mice. The agent inhibits general arthritis symptoms, anti-type-II collagen antibody production and type II collagen-induced delayed type hypersensitivity (DTH) in arthritic mice. Zn-PP-2Na, however, did not affect carrageenin-induced paw edema and histamine- and serotonin-induced skin reactions in rats. Zn-PP-2Na inhibits IL-1-induced mouse lymphocyte proliferation, but does not affect PMA-induced O2- generation from guinea-pig neutrophil. These results indicate that Zn-PP-2Na inhibits type II collagen-induced arthritis in mice due to the antagonism of IL-1 activity and the inhibition of DTH against type II collagen.

Indexed as

AnaphylaxisAnimalsAnti-Inflammatory Agents, Non-SteroidalArthritisArthus ReactionAscarisCollagenEdemaHypersensitivityInterleukin-1LymphocytesMaleMiceMice, Inbred BALB CMice, Inbred DBAOvalbuminAnti-Inflammatory Agents, Non-SteroidalCollagenInterleukin-1OvalbuminProtoporphyrinszinc protoporphyrin

Identifiers

PMID1295376
OpenAlexW2069511460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.